1: Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

Could hepatitis B finally have a finite treatment option? Tatyana Kushner, MD, joins hosts Nancy Reau, MD, and Kimberly Brown, MD, to break down the phase 3 B-Well data for bepirovirsen, the first agent to hit functional cure as a primary endpoint in chronic hepatitis B. The conversation covers the phase 3 B-Well 1 and B-Well 2 results, published in the New England Journal of Medicine and…